Skip to main content
. 2024 Mar 8;14:1362826. doi: 10.3389/fonc.2024.1362826

Table 3.

Univariable and multivariate Cox regression analysis for prognostic factors of MBC related to disease-free survival1.

Factors Univariable Cox regression Multivariate Cox regression
HR (95%CI) P-value HR (95%CI) P-value
Age(years) 1.06(1.02-1.09) 0.001 1.06(1.02-1.10) 0.007
Tumor size(cm)
 < 2.0 1.00(reference) 1.00(reference)
 ≥ 2.0 3.19(1.57-6.47) 0.001 2.55(1.05-6.17) 0.038
Differentiation
 Well 1.00(reference) 1.00(reference)
 Moderate 1.42(0.43-4.73) 0.566 1.16(0.33-4.05) 0.822
 Poor/
 undifferentiated
3.98(1.37-11.55) 0.011 3.23(1.03-10.12) 0.044
TNM stage
 I 1.00(reference) 1.00(reference)
 II 1.56(0.69-3.53) 0.289 1.84(0.65-5.20) 0.248
 III 1.72(0.61-4.84) 0.304 0.87(0.25-2.97) 0.818
 IV 29.50(7.62-114.18) 9.499E-7 31.59(6.01-165.93) 4.500E-5
Ki67
 ≤15% 1.00(reference) 1.00(reference)
 >15% 2.74(1.41-5.35) 0.003 1.20(0.53-2.73) 0.659
LMR
 < 3.67 1.00(reference) 1.00(reference)
 ≥ 3.67 0.50(0.26-0.96) 0.037 0.97(0.44-2.13) 0.933

HR, hazard ratio; CI, confidence interval; PR, progesterone receptor; LMR, lymphocyte-to-monocyte ratio; PLR, platelet-to-lymphocyte ratio.

1Only patients who did not develop distant metastases during the follow-up period were retained in this analysis.